INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
08/06/2026
Back to search
Official data from USPTO
ARTIVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 35
Filing date
09/29/2017
Registration date
12/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/17/2025
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
San Diego, US
Examiner
BILLINGS, JOHN T
Current location
Historical data usage
Holders and representatives
Holders
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.
GREEN CROSS HOLDINGS CORPORATION
Representatives
John P. McCormick Fish & Richardson P.C.
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; Thyroid and para-thyroid hormone preparations; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical agents affecting metabolism; Vaccines against flu; veterinary vaccines; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Virucides; Vaccine preparations; Adrenal hormone preparations; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations for use in urology; Vitamin tablets; Pharmaceutical preparations for wounds; Pharmaceutical preparations for activating cellular function; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Reagents for use in veterinary genetic testing; Pharmaceutical preparations for the treatment of cardiovascular disease; Ophthalmic preparations; Ophthalmologic preparations; Eye drops; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the prevention of cancer; Biological preparations for the treatment of cancer; Pharmaceutical agents for epidermis; Sanitary sterilising preparations; Medicines for the treatment of gastrointestinal diseases; medicated mouth treatment preparations; Parasiticides for medical use; Diagnostic preparations for medical or veterinary purposes; Cleansing solutions for medical use; Cardiovascular agents for medical purposes; Reagents for medical use; Reagents for use in medical genetic testing; Hemostatics for medical purposes; Antibacterial substances for medical purposes; Diuretics; Insulin; Human vaccine preparations; General anesthetics; Pharmaceutical preparations for the treatment of auto-immune diseases; Multivitamin preparations; Pharmaceutical preparations acting on the central nervous system; Styptic pencils; Pharmaceutical preparations for treating asthma; Pharmaceutical solutions used in dialysis; Penicillin preparations; Antimicrobials for dermatologic use; Pharmaceutical preparations for treating skin disorders; Contraceptive preparations; Antihypertensives; Anti-diabetic pharmaceuticals; Antitoxins; Antivirals; Antiarrhythmic agents; Antibiotic preparations; Anti-cancer preparations; Anticoagulants; Tumor suppressing agents; Antifungal preparations; Anti-dermoinfectives; Antidotes; Antipyretic analgesics; Vasoconstrictors; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Mixed antibiotic preparations; Mixed hormone preparations; Chemotherapeutics; Pharmaceutical preparations for use in discouraging the smoking habit
Class 35
Retail and wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies ; Advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products
Publications
History of USPTO decisions and trademark events.
58 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/10/2026
INPC
INVALIDATION PROCESSED
07/10/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/17/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/17/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
04/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/17/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/14/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
11/27/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/15/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/15/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/15/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/15/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/15/2021
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12/29/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/25/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/23/2020
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
04/24/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/23/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/14/2020
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
02/05/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/05/2020
PLGL
ASSIGNED TO PARALEGAL
02/05/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/20/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
11/18/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/18/2019
PLGL
ASSIGNED TO PARALEGAL
11/18/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/12/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/18/2019
FIMP
FINAL DISPOSITION PROCESSED
03/18/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/18/2018
PUBO
PUBLISHED FOR OPPOSITION
09/18/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/15/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/29/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/29/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/29/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2018
ALIE
ASSIGNED TO LIE
07/20/2018
ALIE
ASSIGNED TO LIE
07/18/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/06/2018
RFNT
REFUSAL PROCESSED BY IB
02/10/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/20/2018
RFRR
REFUSAL PROCESSED BY MPU
01/20/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/10/2018
CNRT
NON-FINAL ACTION WRITTEN
01/09/2018
DOCK
ASSIGNED TO EXAMINER
01/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/23/2017
Continuous trademark protection
Get notified about every new filing that threatens ARTIVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.